CD8A and neoplasm: Therefore, we evaluated the percentages of CD4+ and CD8+ T cells, which are among the main effector cells involved in the eradication of tumor, as well as MDSCs, which can interact with other immune cells to inhibit the immune response and ensure tumor cell survival.36